NNC0519-0130
A Research Study of a New Medicine NNC0519-0130 in Healthy People, People With High Body Weight and People With Type 2 Diabetes.
Novo Nordisk · Phase 1 · Completed · Enrollment 161
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.